ICM
- Biotech or pharma, therapeutic R&D
ICM is a South Korean company that uses AAV gene therapy platform to develop treatments for several diseases. These include osteoarthritis (OA), degenerative retina diseases including AMD (Age-related Macular Degeneration), and sensorineural hearing loss (PDS/DFNB4).